Updates are available Correction dated 2021-04-01
Click to view Correction: https://doi.org/10.1186/s13023-021-01786-5
-
Authors
Rodríguez-Rubio, Enrique https://orcid.org/0000-0002-3233-2283
Gil-Peña, Helena
Chocron, Sara
Madariaga, Leire
de la Cerda-Ojeda, Francisco
Fernández-Fernández, Marta
de Lucas-Collantes, Carmen
Gil, Marta
Luis-Yanes, María Isabel
Vergara, Inés
González-Rodríguez, Juan David
Ferrando, Susana
Antón-Gamero, Montserrat
Carrasco Hidalgo-Barquero, Marta
Fernández-Escribano, Angustias
Fernández-Maseda, Mº Ángeles
Espinosa, Laura
Oliet, Aniana
Vicente, Antonio
Ariceta, Gema
Santos, Fernando
,
-
Funding
Funding for this research was provided by:
Fundación Nutrición y Crecimiento
Fondo de Investigaciones Sanitarias
Kyowa Kirin Farmacéutica S.L.U.
- License Information
-
More Information
Article History
Received: 25 June 2020
Accepted: 3 February 2021
First Online: 27 February 2021
Change Date: 1 April 2021
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1186/s13023-021-01786-5
Ethics approval and consent to participate
: Patients information has been processed via RenalTube database where patients signed their consent to participate in scientific studies.
: Patients or parents signed consent for publication of their data through RenalTube consent form.
: The study has been partially funded by Kyowa Kirin Farmacéutica S.L.U. This company produces the drug Crysvita® (burosumab). Nevertheless, no patients in this study had been or were being treated with burosumab at the time of data collection.
